Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the ...
So when my husband, Andrew, volunteered to undergo private screening as part of our campaign coverage, my curiosity was largely about seeing a system in action. At 51, with no urinary symptoms and no ...
We demonstrate that patients with luminal B tumors derive clinically meaningful benefits … from the addition of apalutamide to secondary radiotherapy,” Dr Daniel Spratt said, adding that these ...
I survived anxiety. I survived fear. I survived grief. I survived the sadness. I now wake up each day with peace, joy, confidence, and expectation. And I live every moment with urgency. I’ve got stuff ...
A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...
After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...
Prostate cancer is something more than half of all men will harbor at some point if they live long enough, but when you're ...
The United States Prostate Cancer Biomarkers Market is projected to grow from $1.48 billion in 2024 to $3.54 billion by 2033, ...
Nubeqa® (darolutamide) plus androgen deprivation therapy (ADT) is now available through NHS England and Wales as an option for treating adult patients with hormone-sensitive metastatic prostate cancer ...
Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...
The 82-year-old was diagnosed with an aggressive form of prostate cancer in May. His daughter celebrated his successful ...
On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...